These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1246250)

  • 1. Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate.
    Daubresse JC; Luyckx AS; Lefebvre PJ
    N Engl J Med; 1976 Mar; 294(11):613. PubMed ID: 1246250
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
    Jain AK; Ryan JR; McMahon FG
    N Engl J Med; 1975 Dec; 293(25):1283-6. PubMed ID: 171574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
    Gatti A; Carletta C
    Clin Ter; 1979 Oct; 91(1):57-65. PubMed ID: 397871
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regadrin treatment of diabetes mellitus].
    Hohlfeld R; Neugebauer A; Haaser B; Marek H; Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:154-6. PubMed ID: 4734038
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of hypoglycemic response to intravenous tolbutamide by clofibrate.
    Ferrari C; Frezzati S; Testori GP; Bertazzoni A
    N Engl J Med; 1976 May; 294(21):1184. PubMed ID: 1264124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sulfonylureas and diabetes mellitus].
    Ascaso JF
    Med Clin (Barc); 1983 Sep; 81(7):302-4. PubMed ID: 6645672
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with a new hypoglycemic agent, glibenclamide, HB 419 (Daonil) in diabetes mellitus.
    Ser I
    Isr J Med Sci; 1972 Jun; 8(6):887. PubMed ID: 4626318
    [No Abstract]   [Full Text] [Related]  

  • 8. [HB 419 (glibenclamide) and possibilities of its combinations in the treatment of diabetes mellitus].
    Stratmann FW
    Dtsch Med J; 1970 Jan; 21(2):83-7. PubMed ID: 5001692
    [No Abstract]   [Full Text] [Related]  

  • 9. Actual problems of the hypoglycaemic sulfonylureas.
    Káldor A
    Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfonylureas: background and development of the field.
    Levine R
    Diabetes Care; 1984; 7 Suppl 1():3-7. PubMed ID: 6376027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glibenclamide-phenformin in diabetics with failures after sulfonylureas].
    Garcia Viveros M; Prado R; Rull JA; Lozano-Castañeda O
    Prensa Med Mex; 1971 Dec; 36(11):522-5. PubMed ID: 5003829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glibenclamide: its therapeutic effect in diabetes mellitus].
    Concha E; Veit O
    Rev Med Chil; 1971 Mar; 99(3):217-9. PubMed ID: 4999506
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of renal insufficiency on the hypoglycemic action of sulfonylureas. Kinetics of chlorpropamide in a case of nephropathy].
    Pettipierre B; Fabre J
    Schweiz Med Wochenschr; 1972 Apr; 102(16):570-8. PubMed ID: 5019376
    [No Abstract]   [Full Text] [Related]  

  • 14. Which sulphonylurea in diabetes mellitus?
    Drug Ther Bull; 1981 Jun; 19(13):49-51. PubMed ID: 7249943
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds].
    Grujić M; Rizvanbegović B; Perinović M; Perinović ID
    Med Arh; 1976; 30(2):119-21. PubMed ID: 971371
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypoglycemic effect of diamicron in diabetic patients].
    Balabolkin MI; Morozova TP; Zhizhina SA; Gavriliuk LI
    Klin Med (Mosk); 1983 Jan; 61(1):87-9. PubMed ID: 6834765
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus].
    Polosa P; Mughini L
    Clin Ter; 1978 Jan; 84(2):135-40. PubMed ID: 648096
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
    Albert J; Ekoé JM
    Sem Hop; 1983 Sep; 59(29-30):2135-40. PubMed ID: 6312587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral hypoglycemic therapy of diabetes mellitus].
    Montenero P
    Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.